Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Jeffrey M Leiden. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Jeffrey M Leiden har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:VRTX / Vertex Pharmaceuticals Incorporated | Executive Chairman, Director | 24 026 |
US:REVH / Revolution Healthcare Acquisition Corp - Class A | Director | 7 500 |
US:DGX / Quest Diagnostics Incorporated | Director | 6 000 |
US:ABT / Abbott Laboratories | President and COO, Director | 303 247 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Jeffrey M Leiden. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Jeffrey M Leiden som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −6 066 | 24 026 | −20,16 | 463,46 | −2 811 348 | 11 135 090 | |
2025-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 525 | 30 092 | −7,74 | 450,83 | −1 138 346 | 13 566 376 | |
2025-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 7 209 | 32 617 | 28,37 | ||||
2025-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 15 414 | 25 408 | 154,23 | ||||
2024-09-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 784 | 9 994 | −27,46 | 499,00 | −1 888 216 | 4 987 006 |
2024-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −4 118 | 13 778 | −23,01 | 420,58 | −1 731 948 | 5 794 751 | |
2024-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 655 | 17 896 | −20,64 | 419,16 | −1 951 190 | 7 501 287 |
2024-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 356 | 22 551 | −16,19 | 419,04 | −1 825 338 | 9 449 771 |
2024-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −737 | 26 907 | −2,67 | 419,13 | −308 899 | 11 277 531 |
2024-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −647 | 27 644 | −2,29 | 420,39 | −271 992 | 11 621 261 |
2024-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 009 | 28 291 | −6,63 | 419,22 | −842 213 | 11 860 153 |
2024-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −8 048 | 30 300 | −20,99 | 422,74 | −3 402 212 | 12 809 022 | |
2024-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 698 | 38 348 | −6,57 | 421,73 | −1 137 828 | 16 172 502 | |
2024-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 7 707 | 41 046 | 23,12 | ||||
2024-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 20 452 | 33 339 | 158,70 | ||||
2024-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 10 464 | 12 887 | 431,86 | ||||
2024-01-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 648 | 2 423 | −73,29 | 419,07 | −2 785 977 | 1 015 407 |
2023-12-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 9 071 | −1,09 | 400,19 | −40 019 | 3 630 123 |
2023-12-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −13 254 | 9 171 | −59,10 | 399,41 | −5 293 780 | 3 662 989 |
2023-10-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −12 962 | 22 425 | −36,63 | 374,00 | −4 847 788 | 8 386 950 |
2023-05-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 125 | 35 387 | −3,08 | 349,00 | −392 625 | 12 350 063 |
2023-05-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −171 | 36 512 | −0,47 | 350,30 | −59 901 | 12 790 154 |
2023-05-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −708 | 36 683 | −1,89 | 349,38 | −247 361 | 12 816 307 |
2023-05-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −700 | 37 391 | −1,84 | 351,59 | −246 113 | 13 146 302 |
2023-05-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 800 | 38 091 | −4,51 | 350,53 | −630 954 | 13 352 038 |
2023-05-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 008 | 39 891 | −4,79 | 349,22 | −701 234 | 13 930 735 |
2023-05-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 41 899 | −0,71 | 353,18 | −105 954 | 14 797 889 |
2023-05-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 505 | 42 199 | −3,44 | 350,48 | −527 472 | 14 789 906 |
2023-05-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 645 | 43 704 | −9,61 | 349,48 | −1 623 335 | 15 273 674 |
2023-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −13 730 | 48 349 | −22,12 | 289,12 | −3 969 618 | 13 978 663 | |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −13 344 | 62 079 | −17,69 | 298,26 | −3 979 981 | 18 515 683 | |
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 578 | 75 423 | −4,53 | 317,83 | −1 137 196 | 23 971 692 | |
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 10 226 | 79 001 | 14,87 | ||||
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 34 890 | 68 775 | 102,97 | ||||
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 31 462 | 33 885 | 1 298,47 | ||||
2022-07-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 471 | 2 423 | −81,21 | 283,42 | −2 967 691 | 686 727 |
2022-07-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −40 666 | 12 894 | −75,93 | 282,43 | −11 485 298 | 3 641 652 |
2022-07-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −34 090 | 53 560 | −38,89 | 281,27 | −9 588 494 | 15 064 821 |
2022-07-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −32 983 | 87 650 | −27,34 | 280,37 | −9 247 444 | 24 574 430 |
2022-07-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −13 869 | 120 633 | −10,31 | 279,44 | −3 875 553 | 33 709 686 |
2022-07-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 60 342 | 134 502 | 81,37 | 91,05 | 5 494 139 | 12 246 407 | |
2022-04-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −15 789 | 74 160 | −17,55 | 289,04 | −4 563 653 | 21 435 206 |
2022-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −12 141 | 89 949 | −11,89 | 227,86 | −2 766 448 | 20 495 779 | |
2022-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −8 236 | 102 090 | −7,47 | 232,51 | −1 914 952 | 23 736 946 | |
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −6 279 | 110 326 | −5,38 | 243,63 | −1 529 753 | 26 878 723 | |
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 17 445 | 116 605 | 17,59 | ||||
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 20 928 | 99 160 | 26,75 | ||||
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 28 444 | 78 232 | 57,13 | ||||
2021-03-17 | 3 | REVH |
Revolution Healthcare Acquisition Corp.
Class B common stock |
7 500 | ||||||||
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −13 970 | 49 676 | −21,95 | 211,75 | −2 958 148 | 10 518 893 | |
2021-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −13 954 | 63 646 | −17,98 | 214,16 | −2 988 389 | 13 630 427 | |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −8 599 | 77 600 | −9,98 | 215,03 | −1 849 043 | 16 686 328 | |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 20 928 | 86 199 | 32,06 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 31 462 | 65 271 | 93,06 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 31 498 | 33 809 | 1 362,96 | ||||
2020-07-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 2 261 | −8,13 | 291,34 | −58 268 | 658 720 |
2020-07-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 534 | 2 461 | −50,73 | 290,51 | −736 152 | 714 945 |
2020-07-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −500 | 4 995 | −9,10 | 289,39 | −144 695 | 1 445 503 |
2020-07-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 318 | 5 495 | −19,35 | 287,91 | −379 465 | 1 582 065 |
2020-07-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 885 | 6 813 | −41,76 | 287,23 | −1 403 119 | 1 956 898 |
2020-07-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 321 | 11 698 | −41,57 | 286,13 | −2 380 888 | 3 347 149 |
2020-07-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −9 233 | 20 019 | −31,56 | 285,11 | −2 632 421 | 5 707 617 |
2020-07-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 801 | 29 252 | −16,55 | 284,14 | −1 648 296 | 8 311 663 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −24 348 | 0 | −100,00 | ||||
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 470 | 93 866 | −4,55 | ||||
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −35 499 | 0 | −100,00 | ||||
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −24 215 | 0 | −100,00 | ||||
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 34 983 | −0,29 | 288,42 | −28 842 | 10 089 797 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −9 630 | 35 083 | −21,54 | 287,81 | −2 771 610 | 10 097 238 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −15 792 | 44 713 | −26,10 | 286,70 | −4 527 566 | 12 819 217 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 391 | 60 505 | −12,18 | 285,68 | −2 397 141 | 17 285 068 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 179 | 68 896 | −12,87 | 285,06 | −2 901 626 | 19 639 494 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −9 219 | 79 075 | −10,44 | 283,86 | −2 616 905 | 22 446 230 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −9 780 | 88 294 | −9,97 | 282,66 | −2 764 415 | 24 957 182 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −9 398 | 98 074 | −8,74 | 281,83 | −2 648 638 | 27 640 195 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 498 | 107 472 | −5,70 | 280,76 | −1 824 378 | 30 173 839 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 940 | 113 970 | −1,67 | 278,96 | −541 182 | 31 793 071 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 428 | 115 910 | −3,68 | 277,94 | −1 230 718 | 32 216 025 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −9 015 | 120 338 | −6,97 | 277,14 | −2 498 417 | 33 350 473 |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 24 348 | 129 353 | 23,19 | 155,57 | 3 787 818 | 20 123 446 | |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 470 | 105 005 | 4,45 | 91,05 | 406 994 | 9 560 705 | |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 35 499 | 100 535 | 54,58 | 96,87 | 3 438 788 | 9 738 825 | |
2020-05-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 24 215 | 65 036 | 59,32 | 187,53 | 4 541 039 | 12 196 201 | |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −24 349 | 24 348 | −50,00 | ||||
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 470 | 98 336 | −4,35 | ||||
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −35 499 | 35 499 | −50,00 | ||||
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −24 216 | 24 215 | −50,00 | ||||
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 607 | 40 821 | −12,08 | 272,41 | −1 527 403 | 11 120 049 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −14 131 | 46 428 | −23,33 | 271,61 | −3 838 121 | 12 610 309 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −13 885 | 60 559 | −18,65 | 270,43 | −3 754 921 | 16 376 970 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −30 237 | 74 444 | −28,88 | 269,52 | −8 149 476 | 20 064 147 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −24 617 | 104 681 | −19,04 | 268,63 | −6 612 865 | 28 120 457 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 892 | 129 298 | −4,36 | 267,52 | −1 576 228 | 34 589 801 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 24 349 | 135 190 | 21,97 | 155,57 | 3 787 974 | 21 031 508 | |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 470 | 110 841 | 4,20 | 91,05 | 406 994 | 10 092 073 | |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 35 499 | 106 371 | 50,09 | 96,87 | 3 438 788 | 10 304 159 | |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 24 216 | 70 872 | 51,90 | 187,53 | 4 541 226 | 13 290 626 | |
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −24 349 | 48 697 | −33,33 | ||||
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 470 | 102 806 | −4,17 | ||||
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −35 502 | 70 998 | −33,34 | ||||
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −24 216 | 48 431 | −33,33 | ||||
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 375 | 46 656 | −10,33 | 273,70 | −1 471 138 | 12 769 747 |
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −12 849 | 52 031 | −19,80 | 272,97 | −3 507 392 | 14 202 902 |
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −11 832 | 64 880 | −15,42 | 272,12 | −3 219 724 | 17 655 146 |
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 003 | 76 712 | −7,26 | 270,86 | −1 625 973 | 20 778 212 |
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −15 681 | 82 715 | −15,94 | 269,56 | −4 226 970 | 22 296 655 |
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −22 613 | 98 396 | −18,69 | 268,86 | −6 079 731 | 26 454 749 |
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 878 | 121 009 | −8,25 | 267,62 | −2 911 170 | 32 384 429 |
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 921 | 131 887 | −3,60 | 266,66 | −1 312 234 | 35 168 987 |
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 220 | 136 808 | −2,99 | 265,57 | −1 120 705 | 36 332 101 |
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 24 349 | 141 028 | 20,87 | 155,57 | 3 787 974 | 21 939 726 | |
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 470 | 116 679 | 3,98 | 91,05 | 406 994 | 10 623 623 | |
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 35 502 | 112 209 | 46,28 | 96,87 | 3 439 079 | 10 869 686 | |
2020-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 24 216 | 76 707 | 46,13 | 187,53 | 4 541 226 | 14 384 864 | |
2020-04-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −40 090 | 52 491 | −43,30 | 234,01 | −9 381 461 | 12 283 419 | |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 680 | 92 581 | −1,78 | 238,33 | −400 394 | 22 064 830 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −560 | 94 261 | −0,59 | 236,63 | −132 513 | 22 304 980 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 210 | 94 821 | −1,26 | 235,53 | −284 991 | 22 333 190 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 640 | 96 031 | −1,68 | 234,49 | −384 564 | 22 518 309 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 017 | 97 671 | −1,03 | 232,96 | −236 920 | 22 753 436 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 050 | 98 688 | −1,05 | 231,76 | −243 348 | 22 871 931 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 120 | 99 738 | −1,11 | 230,40 | −258 048 | 22 979 635 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 273 | 100 858 | −2,20 | 229,77 | −522 267 | 23 174 143 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −8 410 | 103 131 | −7,54 | 239,23 | −2 011 924 | 24 672 029 | |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 763 | 111 541 | −1,56 | 245,66 | −433 099 | 27 401 162 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 030 | 113 304 | −1,76 | 244,87 | −497 086 | 27 744 750 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 971 | 115 334 | −1,68 | 243,65 | −480 234 | 28 101 129 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 241 | 117 305 | −3,49 | 242,61 | −1 028 909 | 28 459 366 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 680 | 121 546 | −1,36 | 241,78 | −406 190 | 29 387 392 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −9 314 | 123 226 | −7,03 | 241,50 | −2 249 331 | 29 759 079 | |
2020-02-14 |
|
4/A | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 31 462 | 216 818 | 16,97 | ||||
2020-02-14 |
|
4/A | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 28 444 | 185 356 | 18,13 | ||||
2020-02-14 |
|
4/A | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 50 566 | 156 912 | 47,55 | ||||
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 609 | 132 540 | −3,36 | 248,45 | −1 145 106 | 32 929 563 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −7 533 | 137 149 | −5,21 | 247,49 | −1 864 342 | 33 943 006 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −14 433 | 144 682 | −9,07 | 246,27 | −3 554 415 | 35 630 836 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −14 024 | 159 115 | −8,10 | 245,37 | −3 441 069 | 39 042 048 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 124 | 173 139 | −2,33 | 244,56 | −1 008 565 | 42 342 874 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 800 | 177 263 | −1,56 | 243,37 | −681 436 | 43 140 496 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −36 755 | 180 063 | −16,95 | 240,95 | −8 856 117 | 43 386 180 | |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 31 462 | 216 818 | 16,97 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 28 444 | 185 356 | 18,13 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 50 566 | 156 912 | 47,55 | ||||
2019-11-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −32 502 | 0 | −100,00 | ||||
2019-11-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −64 032 | 0 | −100,00 | ||||
2019-11-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 615 | 106 346 | −9,08 | 212,75 | −2 258 341 | 22 625 112 |
2019-11-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −23 033 | 116 961 | −16,45 | 211,43 | −4 869 867 | 24 729 064 |
2019-11-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −62 886 | 139 994 | −31,00 | 210,41 | −13 231 843 | 29 456 138 |
2019-11-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 32 502 | 202 880 | 19,08 | 131,89 | 4 286 689 | 26 757 843 | |
2019-11-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 64 032 | 170 378 | 60,21 | 109,14 | 6 988 452 | 18 595 055 | |
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 493 | 32 502 | −4,39 | ||||
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 941 | 64 032 | −4,39 | ||||
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 493 | 106 346 | −1,38 | 210,00 | −313 530 | 22 332 660 |
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 493 | 107 839 | 1,40 | 131,89 | 196 912 | 14 222 886 | |
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 941 | 106 346 | −2,69 | 210,00 | −617 610 | 22 332 660 |
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 941 | 109 287 | 2,77 | 109,14 | 320 981 | 11 927 583 | |
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 683 | 33 995 | −4,72 | ||||
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −3 317 | 66 973 | −4,72 | ||||
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 683 | 106 346 | −1,56 | 210,00 | −353 430 | 22 332 660 |
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 683 | 108 029 | 1,58 | 131,89 | 221 971 | 14 247 945 | |
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 317 | 106 346 | −3,02 | 210,00 | −696 570 | 22 332 660 |
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 317 | 109 663 | 3,12 | 109,14 | 362 017 | 11 968 620 | |
2019-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −26 532 | 35 678 | −42,65 | ||||
2019-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −70 290 | 70 290 | −50,00 | ||||
2019-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −26 532 | 106 287 | −19,98 | 200,06 | −5 307 992 | 21 263 777 |
2019-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 26 532 | 132 819 | 24,96 | 131,89 | 3 499 305 | 17 517 498 | |
2019-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −70 290 | 106 287 | −39,81 | 200,00 | −14 058 000 | 21 257 400 |
2019-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 70 290 | 176 577 | 66,13 | 109,14 | 7 671 451 | 19 271 614 | |
2019-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −8 879 | 62 210 | −12,49 | ||||
2019-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 879 | 106 287 | −7,71 | 200,00 | −1 775 800 | 21 257 400 |
2019-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 8 879 | 115 166 | 8,35 | 131,89 | 1 171 051 | 15 189 244 | |
2019-10-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −35 411 | 71 089 | −33,25 | ||||
2019-10-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −72 420 | 140 580 | −34,00 | ||||
2019-10-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −35 411 | 106 287 | −24,99 | 190,00 | −6 728 090 | 20 194 530 |
2019-10-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 35 411 | 141 698 | 33,32 | 131,89 | 4 670 357 | 18 688 549 | |
2019-10-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −72 420 | 106 287 | −40,52 | 190,00 | −13 759 800 | 20 194 530 |
2019-10-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 72 420 | 178 707 | 68,14 | 109,14 | 7 903 919 | 19 504 082 | |
2019-06-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Options (Right to Buy) |
M - Exercise | −56 030 | 0 | −100,00 | ||||
2019-06-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 249 | 106 287 | −3,84 | 176,11 | −748 291 | 18 718 204 |
2019-06-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −51 781 | 110 536 | −31,90 | 175,33 | −9 078 763 | 19 380 277 |
2019-06-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 56 030 | 162 317 | 52,72 | 77,31 | 4 331 679 | 12 548 727 | |
2019-05-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −113 432 | 56 030 | −66,94 | ||||
2019-05-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −113 432 | 106 287 | −51,63 | 175,10 | −19 861 943 | 18 610 854 |
2019-05-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 113 432 | 219 719 | 106,72 | 77,31 | 8 769 428 | 16 986 476 | |
2019-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 300 | 169 462 | 1,38 | ||||
2019-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 30 758 | 171 762 | 21,81 | ||||
2019-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Comomn Stock |
S - Sale | X | −2 300 | 106 195 | −2,12 | 175,02 | −402 546 | 18 586 249 |
2019-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 300 | 108 495 | 2,17 | 77,31 | 177 813 | 8 387 748 | |
2019-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −30 758 | 106 195 | −22,46 | 175,01 | −5 382 958 | 18 585 187 |
2019-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 30 758 | 136 953 | 28,96 | 77,31 | 2 377 901 | 10 587 836 | |
2019-05-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 300 | 202 520 | 0,15 | ||||
2019-05-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 10 180 | 202 820 | 5,28 | ||||
2019-05-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 106 195 | −0,28 | 175,04 | −52 512 | 18 588 373 |
2019-05-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 300 | 106 495 | 0,28 | 77,31 | 23 193 | 8 233 128 | |
2019-05-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 180 | 106 195 | −8,75 | 175,08 | −1 782 314 | 18 592 621 |
2019-05-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 10 180 | 116 375 | 9,59 | 77,31 | 787 016 | 8 996 951 | |
2019-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 200 | 106 195 | −1,12 | 188,61 | −226 332 | 20 029 439 |
2019-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 700 | 107 395 | −2,45 | 187,43 | −506 061 | 20 129 045 |
2019-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −17 097 | 110 095 | −13,44 | 186,80 | −3 193 720 | 20 565 746 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −412 | 127 192 | −0,32 | 181,80 | −74 902 | 23 123 506 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −48 651 | 127 604 | −27,60 | 180,81 | −8 796 587 | 23 072 079 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −47 661 | 176 255 | −21,29 | 179,93 | −8 575 644 | 31 713 562 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −14 707 | 223 916 | −6,16 | 179,28 | −2 636 671 | 40 143 660 |
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 72 647 | 72 647 | |||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 28 444 | 238 623 | 13,53 | ||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 31 498 | 210 179 | 17,63 | ||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 53 816 | 178 681 | 43,10 | ||||
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 124 865 | −0,72 | 187,91 | −169 119 | 23 463 382 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −12 951 | 125 765 | −9,34 | 186,70 | −2 417 952 | 23 480 326 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −17 099 | 138 716 | −10,97 | 186,10 | −3 182 124 | 25 815 048 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 300 | 155 815 | −0,83 | 184,99 | −240 487 | 28 824 217 |
2018-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −106 500 | 0 | −100,00 | ||||
2018-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −140 211 | 157 049 | −47,17 | 160,00 | −22 433 760 | 25 127 840 |
2018-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 106 500 | 297 260 | 55,83 | 83,36 | 8 877 840 | 24 779 594 | |
2018-05-30 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
S - Sale | −1 644 | 6 000 | −21,51 | 105,61 | −173 623 | 633 660 | |
2018-05-17 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 1 644 | 7 644 | 27,40 | ||||
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 190 658 | −0,10 | 153,89 | −30 778 | 29 340 360 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 000 | 190 858 | −1,04 | 153,29 | −306 580 | 29 256 623 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 200 | 192 858 | −0,62 | 152,40 | −182 880 | 29 391 559 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 100 | 194 058 | −4,95 | 151,23 | −1 527 423 | 29 347 391 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 305 | 204 158 | −2,07 | 150,44 | −647 644 | 30 713 530 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 100 | 208 463 | −2,84 | 149,22 | −910 242 | 31 106 849 |
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 73 046 | 73 046 | |||||
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 31 498 | 214 563 | 17,21 | ||||
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 50 568 | 183 065 | 38,17 | ||||
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −55 313 | 0 | −100,00 | ||||
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −44 250 | 0 | −100,00 | ||||
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −7 995 | 132 497 | −5,69 | 159,39 | −1 274 323 | 21 118 697 |
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −17 918 | 140 492 | −11,31 | 158,79 | −2 845 199 | 22 308 725 |
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −11 471 | 158 410 | −6,75 | 157,67 | −1 808 633 | 24 976 505 |
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −19 808 | 169 881 | −10,44 | 156,62 | −3 102 329 | 26 606 762 |
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −42 371 | 189 689 | −18,26 | 155,77 | −6 600 131 | 29 547 856 |
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 55 313 | 232 060 | 31,30 | 45,11 | 2 495 169 | 10 468 227 | |
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 44 250 | 176 747 | 33,40 | 48,74 | 2 156 745 | 8 614 649 | |
2017-12-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 198 | 132 497 | −3,78 | 143,39 | −745 341 | 18 998 745 |
2017-12-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −12 134 | 137 695 | −8,10 | 142,21 | −1 725 576 | 19 581 606 |
2017-12-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −87 578 | 149 829 | −36,89 | 141,35 | −12 379 150 | 21 178 329 |
2017-12-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −20 090 | 237 407 | −7,80 | 140,31 | −2 818 828 | 33 310 576 |
2017-08-08 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
S - Sale | −296 | 6 000 | −4,70 | 106,66 | −31 571 | 639 954 | |
2017-08-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −11 063 | 55 313 | −16,67 | ||||
2017-08-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −700 | 257 392 | −0,27 | 154,05 | −107 835 | 39 651 238 |
2017-08-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 000 | 258 092 | −1,90 | 153,24 | −766 200 | 39 550 018 |
2017-08-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 363 | 263 092 | −2,00 | 152,25 | −816 517 | 40 055 757 |
2017-08-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 11 063 | 268 455 | 4,30 | 45,11 | 499 052 | 12 110 005 | |
2017-07-31 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
S - Sale | −1 304 | 6 296 | −17,16 | 108,73 | −141 783 | 684 558 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 058 | 257 392 | −1,93 | 162,08 | −819 801 | 41 718 095 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −17 255 | 262 450 | −6,17 | 161,43 | −2 785 475 | 42 367 304 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 279 705 | −0,32 | 160,42 | −144 378 | 44 870 276 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 500 | 280 605 | −1,23 | 159,34 | −557 690 | 44 711 601 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 837 | 284 105 | −1,67 | 158,46 | −766 471 | 45 019 278 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −700 | 288 942 | −0,24 | 157,42 | −110 194 | 45 485 250 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −73 750 | 44 250 | −62,50 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −110 624 | 66 376 | −62,50 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −184 374 | 289 642 | −38,90 | 161,00 | −29 684 214 | 46 632 362 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 73 750 | 474 016 | 18,43 | 48,74 | 3 594 575 | 23 103 540 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 110 624 | 400 266 | 38,19 | 45,11 | 4 990 249 | 18 055 999 | |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −124 601 | 0 | −100,00 | ||||
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −22 500 | 0 | −100,00 | ||||
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −147 101 | 289 642 | −33,68 | 129,50 | −19 049 580 | 37 508 639 |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 124 601 | 436 743 | 39,92 | 29,98 | 3 735 538 | 13 093 555 | |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 22 500 | 312 142 | 7,77 | 53,85 | 1 211 625 | 16 808 847 | |
2017-05-18 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 1 573 | 7 600 | 26,10 | ||||
2017-04-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2017-04-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2017-04-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 527 | 0 | −100,00 | ||||
2017-04-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −88 507 | 124 601 | −41,53 | ||||
2017-04-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −157 200 | 289 479 | −35,19 | 119,50 | −18 785 400 | 34 592 740 |
2017-04-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 30 000 | 446 679 | 7,20 | 34,05 | 1 021 500 | 15 209 420 | |
2017-04-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 20 000 | 416 679 | 5,04 | 34,24 | 684 800 | 14 267 089 | |
2017-04-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 527 | 396 679 | 0,39 | 34,39 | 52 514 | 13 641 791 | |
2017-04-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 88 507 | 395 152 | 28,86 | 29,98 | 2 653 440 | 11 846 657 | |
2017-02-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 306 645 | −0,03 | 88,39 | −8 839 | 27 104 352 |
2017-02-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −23 804 | 306 745 | −7,20 | 87,68 | −2 087 135 | 26 895 402 |
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 103 550 | 103 550 | |||||
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 50 567 | 330 549 | 18,06 | ||||
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 17 895 | 279 982 | 6,83 | 0,01 | 179 | 2 800 | |
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
M - Exercise | −311 | 0 | −100,00 | 70,37 | −21 885 | ||
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
M - Exercise | −1 747 | 0 | −100,00 | 61,37 | −107 213 | ||
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
M - Exercise | −1 563 | 0 | −100,00 | 72,92 | −113 974 | ||
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
M - Exercise | −1 518 | 0 | −100,00 | 76,06 | −115 467 | ||
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
M - Exercise | −1 502 | 0 | −100,00 | 68,68 | −103 157 | ||
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
S - Sale | −311 | 6 027 | −4,91 | 85,61 | −26 625 | 515 977 | |
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
M - Exercise | 311 | 6 338 | 5,16 | 70,37 | 21 885 | 446 005 | |
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
S - Sale | −1 747 | 6 027 | −22,47 | 85,57 | −149 486 | 515 712 | |
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
M - Exercise | 1 747 | 7 774 | 28,99 | 61,37 | 107 213 | 477 090 | |
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
S - Sale | −1 563 | 6 027 | −20,59 | 85,65 | −133 866 | 516 194 | |
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
M - Exercise | 1 563 | 7 590 | 25,93 | 72,92 | 113 974 | 553 463 | |
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
S - Sale | −800 | 6 027 | −11,72 | 85,66 | −68 526 | 516 261 | |
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
S - Sale | −718 | 6 827 | −9,52 | 85,65 | −61 497 | 584 733 | |
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
M - Exercise | 1 518 | 7 545 | 25,19 | 76,06 | 115 467 | 573 910 | |
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
S - Sale | −1 206 | 6 027 | −16,67 | 85,62 | −103 263 | 516 056 | |
2016-08-04 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
M - Exercise | 1 502 | 7 233 | 26,21 | 68,68 | 103 157 | 496 762 | |
2016-05-19 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 2 196 | 5 731 | 62,12 | ||||
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 034 | 261 885 | −0,39 | 92,87 | −96 028 | 24 321 260 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 262 919 | −0,34 | 91,96 | −82 764 | 24 178 031 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 700 | 263 819 | −1,38 | 91,01 | −336 737 | 24 010 167 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 200 | 267 519 | −1,55 | 89,91 | −377 622 | 24 052 633 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 107 276 | 107 276 | |||||
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 53 817 | 271 719 | 24,70 | 0,01 | 538 | 2 717 | |
2016-01-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
G - Gift | 110 625 | 110 625 | |||||
2016-01-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
G - Gift | −110 625 | 66 375 | −62,50 | ||||
2016-01-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
G - Gift | 88 500 | 88 500 | |||||
2016-01-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
G - Gift | −88 500 | 29 500 | −75,00 | ||||
2016-01-06 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
A - Award | 311 | 311 | |||||
2015-11-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −16 125 | 217 902 | −6,89 | 130,00 | −2 096 250 | 28 327 260 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 233 923 | −0,09 | 126,86 | −25 372 | 29 675 472 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 125 | 234 123 | −3,35 | 126,31 | −1 026 269 | 29 572 076 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 800 | 242 248 | −1,94 | 125,35 | −601 680 | 30 365 787 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 400 | 247 048 | −0,56 | 124,33 | −174 062 | 30 715 478 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 600 | 248 448 | −0,64 | 123,34 | −197 344 | 30 643 576 |
2015-10-05 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
A - Award | 1 747 | 1 747 | |||||
2015-07-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 106 500 | 106 500 | |||||
2015-07-02 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
A - Award | 1 563 | 1 563 | |||||
2015-06-01 |
|
4/A | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 2 340 | 3 535 | 195,82 | ||||
2015-05-19 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 2 340 | 3 858 | 154,15 | ||||
2015-04-02 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
A - Award | 1 518 | 1 518 | |||||
2015-02-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −15 250 | 249 927 | −5,75 | 113,14 | −1 725 385 | 28 276 741 |
2015-02-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −17 000 | 265 177 | −6,02 | 112,67 | −1 915 390 | 29 877 493 |
2015-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
A - Award | 213 000 | 213 000 | |||||
2015-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 64 500 | 282 177 | 29,63 | 0,01 | 645 | 2 822 | |
2015-01-05 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy) |
A - Award | 1 502 | 1 502 | |||||
2014-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 217 677 | −0,09 | 120,17 | −24 034 | 26 158 245 |
2014-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 217 877 | −0,09 | 119,00 | −23 800 | 25 927 363 |
2014-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 700 | 218 077 | −1,22 | 118,05 | −318 735 | 25 743 990 |
2014-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 650 | 220 777 | −3,77 | 117,26 | −1 014 299 | 25 888 311 |
2014-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 400 | 229 427 | −1,46 | 116,27 | −395 318 | 26 675 477 |
2014-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 406 | 232 827 | −2,68 | 115,05 | −737 010 | 26 786 746 |
2014-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −15 440 | 239 233 | −6,06 | 114,21 | −1 763 402 | 27 322 801 |
2014-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −13 021 | 254 673 | −4,86 | 113,19 | −1 473 847 | 28 826 437 |
2014-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
G - Gift | X | −2 500 | 267 694 | −0,93 | |||
2014-12-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 125 000 | 270 194 | 86,09 | 0,01 | 1 250 | 2 702 | |
2014-12-03 |
|
4 | DGX |
QUEST DIAGNOSTICS INC
Common Stock |
A - Award | 1 195 | 1 195 | |||||
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −200 000 | 213 108 | −48,41 | ||||
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −41 704 | 144 992 | −22,34 | 113,90 | −4 750 086 | 16 514 589 |
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −53 750 | 186 696 | −22,35 | 113,10 | −6 079 125 | 21 115 318 |
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −79 817 | 240 446 | −24,92 | 112,21 | −8 956 266 | 26 980 446 |
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −24 729 | 320 263 | −7,17 | 111,31 | −2 752 585 | 35 648 475 |
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 200 000 | 344 992 | 137,94 | 29,98 | 5 996 000 | 10 342 860 | |
2014-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 106 500 | 106 500 | |||||
2014-05-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
D - Sale to Issuer | −66 689 | 144 792 | −31,53 | 0,01 | −667 | 1 448 | |
2014-02-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −35 944 | 211 481 | −14,53 | 80,00 | −2 875 520 | 16 918 480 |
2014-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
A - Award | 213 000 | 213 000 | |||||
2014-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 64 500 | 247 425 | 35,26 | 0,01 | 645 | 2 474 | |
2014-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −45 000 | 413 108 | −9,82 | ||||
2014-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −45 000 | 182 925 | −19,74 | 80,00 | −3 600 000 | 14 634 000 |
2014-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 45 000 | 227 925 | 24,60 | 29,98 | 1 349 100 | 6 833 192 | |
2013-12-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −9 834 | 182 925 | −5,10 | 65,48 | −643 930 | 11 977 929 |
2013-08-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 106 500 | 106 500 | |||||
2013-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −33 345 | 192 371 | −14,77 | 45,83 | −1 528 201 | 8 816 363 |
2013-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
A - Award | 177 000 | 177 000 | |||||
2013-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 39 334 | 225 716 | 21,10 | 0,01 | 393 | 2 257 | |
2012-07-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee StockOption (right to buy) |
A - Award | 118 000 | 118 000 | |||||
2011-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 458 108 | 458 108 | |||||
2011-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 133 378 | 185 995 | 253,49 | 0,01 | 1 334 | 1 860 | |
2011-12-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 50 017 | 52 617 | 1 923,73 | 0,01 | 500 | 526 | |
2009-07-07 | 3 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
0 | ||||||||
2006-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −6 102 | 303 247 | −1,97 | 44,15 | −269 403 | 13 388 355 | |
2006-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 310 000 | 310 000 | |||||
2006-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 000 | 401 247 | −0,50 | 44,41 | −88 820 | 17 819 379 | |
2006-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 100 000 | 403 247 | 32,98 | 44,16 | 4 416 000 | 17 807 388 |